Targeting the Mesenchymal Cancer Cell Phenotype for Therapeutic Gain
Project summary
Most cancer patients die from malignant metastases, or because the patients have become insensitive to chemotherapy. In this project, we aim to identify and repurpose existing drugs to selectively change the behaviour of aggressive cancer cells into non-invasive and therapy sensitive cancer cells or benign fat cells.
Impact
Type the project impact here.
More detailed information
Principal Investigator:
Prof. J.W.M. (John) Martens and prof. S. (Stefan) Sleijfer
Role Erasmus MC:
Partner
Department:
Department
Project website:
Not available
Funding Agency:
ZonMw
